In vivo human time-exposure study of orally dosed commercial silver nanoparticles.

MLA

Munger, Mark A., et al. “In Vivo Human Time-Exposure Study of Orally Dosed Commercial Silver Nanoparticles.” Nanomedicine: Nanotechnology, Biology & Medicine, vol. 10, no. 1, Jan. 2014, pp. 1–9. EBSCOhost, https://doi.org/10.1016/j.nano.2013.06.010.

APA

Munger, M. A., Radwanski, P., Hadlock, G. C., Stoddard, G., Shaaban, A., Falconer, J., Grainger, D. W., & Deering-Rice, C. E. (2014). In vivo human time-exposure study of orally dosed commercial silver nanoparticles. Nanomedicine: Nanotechnology, Biology & Medicine, 10(1), 1–9. https://doi.org/10.1016/j.nano.2013.06.010

Chicago

Munger, Mark A., Przemyslaw Radwanski, Greg C. Hadlock, Greg Stoddard, Akram Shaaban, Jonathan Falconer, David W. Grainger, and Cassandra E. Deering-Rice. 2014. “In Vivo Human Time-Exposure Study of Orally Dosed Commercial Silver Nanoparticles.” Nanomedicine: Nanotechnology, Biology & Medicine 10 (1): 1–9. doi:10.1016/j.nano.2013.06.010.